TAS2940

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS2940, covering 2025-10-14 to 2025-10-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer [Phase 1]